CIRCULATING LEVELS OF ENDOTHELIN IN CIRRHOSIS

被引:178
作者
ASBERT, M
GINES, A
GINES, P
JIMENEZ, W
CLARIA, J
SALO, J
ARROYO, V
RIVERA, F
RODES, J
机构
[1] UNIV BARCELONA,HOSP CLIN & PROV,LIVER UNIT,VILLARROEL 170,E-08036 BARCELONA,SPAIN
[2] UNIV BARCELONA,HOSP CLIN & PROV,HORMONAL LAB,BARCELONA 7,SPAIN
关键词
D O I
10.1016/0016-5085(93)90360-O
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background:Current information concerning endothelin in cirrhosis is conflicting. Plasma endothelin concentration has been found to be increased in some studies and normal or reduced in others. The present study was aimed to investigate the plasma levels of endothelin in cirrhosis and to assess whether it is involved in the renal and hemodynamic disturbances and neurohumoral changes present in this condition. Methods: Renal function, plasma renin activity, and plasma concentration of aldosterone, norepinephrine, antidiuretic hormone, atrial natriuretic factor, and endothelin were measured in 9 healthy subjects, 7 compensated cirrhotics, and 25 cirrhotics with ascites (10 with functional renal failure). Results: Cirrhotics with ascites with and without functional renal failure showed higher endothelin levels (15.6 ± 6.4 and 15.7 ± 4.6 pg/mL, respectively; mean ± SD) than compensated cirrhotics (6.4 ± 1.8 pg/mL) and healthy subjects (3.4 ±1.0 pg/mL) (analysis of variance, F = 21.84; P < 0.001). These patients also showed higher plasma levels of renin, aldosterone, norepinephrine, antidiuretic hormone, and atrial natriuretic factor, although plasma endothelin levels only correlated significantly with plasma atrial natriuretic factor (r = 0.73, P < 0.001) and antidiuretic hormone concentrations (r = 0.59, P < 0.001). In 7 additional nonazotemic cirrhotics with ascites, plasma renin activity and the plasma concentration of aldosterone and endothelin were measured before and 24 hours after the intravenous administration of a saline solution of human serum albumin. Volume expansion markedly suppressed renin and aldosterone but not endothelin (21.03 ± 7.34 vs. 23.97 ± 14.29 pg/mL). Conclusions: Circulating plasma levels of endothelin are elevated in cirrhosis with ascites and do not decrease following plasma volume expansion. © 1993.
引用
收藏
页码:1485 / 1491
页数:7
相关论文
共 44 条
[21]  
MADDEDU P, 1989, J CARDIOVASC PHARM, V14, P818
[22]   INTEGRATED CARDIAC, RENAL, AND ENDOCRINE ACTIONS OF ENDOTHELIN [J].
MILLER, WL ;
REDFIELD, MM ;
BURNETT, JC .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (01) :317-320
[23]  
MIURA K, 1991, J PHARMACOL EXP THER, V256, P11
[24]  
MONCADA S, 1991, PHARMACOL REV, V43, P109
[25]  
MOORE KP, 1991, J AM SOC NEPHROL, V3, P652
[26]  
MOSCA P, 1991, HEPATOLOGY, V14, pA121
[27]   MODULATION OF THE HYPERDYNAMIC CIRCULATION OF CIRRHOTIC RATS BY NITRIC-OXIDE INHIBITION [J].
PIZCUETA, P ;
PIQUE, JM ;
FERNANDEZ, M ;
BOSCH, J ;
RODES, J ;
WHITTLE, BJR ;
MONCADA, S .
GASTROENTEROLOGY, 1992, 103 (06) :1909-1915
[28]  
PIZCUETA P, 1992, BRIT J PHARMACOL, V105, P784
[29]   ENDOTHELIN IN HUMAN-PLASMA AND CULTURE-MEDIUM OF AORTIC ENDOTHELIAL-CELLS - DETECTION AND CHARACTERIZATION WITH RADIOIMMUNOASSAY USING MONOCLONAL-ANTIBODY [J].
SAITO, Y ;
NAKAO, K ;
ITOH, H ;
YAMADA, T ;
MUKOYAMA, M ;
ARAI, H ;
HOSODA, K ;
SHIRAKAMI, G ;
SUGA, S ;
JOUGASAKI, M ;
MORICHIKA, S ;
IMURA, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (01) :320-326
[30]   APPLICATION OF MONOCLONAL-ANTIBODIES FOR ENDOTHELIN TO HYPERTENSIVE RESEARCH [J].
SAITO, Y ;
NAKAO, K ;
MUKOYAMA, M ;
SHIRAKAMI, G ;
ITOH, H ;
YAMADA, T ;
ARAI, H ;
HOSODA, K ;
SUGA, S ;
JOUGASAKI, M ;
OGAWA, Y ;
NAKAJIMA, S ;
UEDA, M ;
IMURA, H .
HYPERTENSION, 1990, 15 (06) :734-738